Literature DB >> 18334868

Correlation between oesophageal acid exposure and dyspeptic symptoms in patients with nonerosive reflux disease.

Giovanni Sarnelli1, Francesco De Giorgi, Eleonora Efficie, Giovanni Aprea, Stefania Masone, Maria Flavia Savarese, Ida Esposito, Luigi Russo, Rosario Cuomo.   

Abstract

BACKGROUND & AIMS: Oesophageal acidification induces dyspeptic symptoms in healthy individuals. This study aimed to evaluate the correlation between oesophageal acid exposure and dyspeptic symptoms in patients with nonerosive reflux disease.
METHODS: A total of 68 patients with dominant symptoms of heartburn, negative upper gastrointestinal endoscopy and concomitant dyspeptic symptoms participated in the study. The severity of dyspepsia and reflux-related symptoms was evaluated, and 24-h gastro-oesophageal pH-monitoring study was performed in all patients at baseline and after 4 weeks of therapy with esomeprazole 40 mg.
RESULTS: Oesophageal basal acid exposure was pathological in 43 patients and normal in 25 patients, with a similar prevalence and severity of individual dyspeptic symptoms in the two groups. A significant correlation between reflux and dyspepsia scores was observed in the subgroup of patients with normal, but not in those with abnormal pHmetry (r=0.4, P=0.04 and r=0.2 P=0.07, respectively). After esomeprazole, a reduction in severity of dyspepsia (>or=50% with respect to baseline) was observed, independent of improvement of reflux-associated symptoms. Improvement in dyspepsia was, however, similar in patients with normal and abnormal basal acid exposure (14/25 vs. 33/43, respectively, P=NS).
CONCLUSION: Dyspeptic symptoms coexist in a subset of nonerosive reflux disease patients, but prevalence and severity of the symptoms seems to be independent of oesophageal acid exposure.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18334868     DOI: 10.1097/MEG.0b013e3282f340b2

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  7 in total

1.  Specific dyspeptic symptoms are associated with poor response to therapy in patients with gastroesophageal reflux disease.

Authors:  A D'Alessandro; F P Zito; M Pesce; P Andreozzi; E Efficie; M Cargiolli; F Maione; G D De Palma; R Cuomo; G Sarnelli
Journal:  United European Gastroenterol J       Date:  2016-07-07       Impact factor: 4.623

2.  Impedance-pH reflux patterns can differentiate non-erosive reflux disease from functional heartburn patients.

Authors:  Edoardo Savarino; Patrizia Zentilin; Radu Tutuian; Daniel Pohl; Lorenzo Gemignani; Alberto Malesci; Vincenzo Savarino
Journal:  J Gastroenterol       Date:  2011-10-25       Impact factor: 7.527

3.  Pathophysiology of functional heartburn based on Rome III criteria in Japanese patients.

Authors:  Yasuhiro Tamura; Yasushi Funaki; Shinya Izawa; Akihito Iida; Yoshiharu Yamaguchi; Kazunori Adachi; Naotaka Ogasawara; Makoto Sasaki; Hiroshi Kaneko; Kunio Kasugai
Journal:  World J Gastroenterol       Date:  2015-04-28       Impact factor: 5.742

4.  Overlap of dyspepsia and gastroesophageal reflux in the general population: one disease or distinct entities?

Authors:  R S Choung; G R Locke; C D Schleck; A R Zinsmeister; N J Talley
Journal:  Neurogastroenterol Motil       Date:  2011-12-12       Impact factor: 3.598

5.  The Therapeutic and Diagnostic Value of 2-week High Dose Proton Pump Inhibitor Treatment in Overlapping Non-erosive Gastroesophageal Reflux Disease and Functional Dyspepsia Patients.

Authors:  Chatchai Kriengkirakul; Tanisa Patcharatrakul; Sutep Gonlachanvit
Journal:  J Neurogastroenterol Motil       Date:  2012-04-09       Impact factor: 4.924

6.  Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease.

Authors:  E Savarino; D Pohl; P Zentilin; P Dulbecco; G Sammito; L Sconfienza; S Vigneri; G Camerini; R Tutuian; V Savarino
Journal:  Gut       Date:  2009-05-20       Impact factor: 23.059

7.  Comparison of gastroesophageal reflux disease symptoms and proton pump inhibitor response using gastroesophageal reflux disease impact scale questionnaire.

Authors:  So Young Jo; Nayoung Kim; Ji Hwan Lim; Cheol Min Shin; Young Soo Park; Dong Ho Lee; Hyun Chae Jung
Journal:  J Neurogastroenterol Motil       Date:  2013-01-08       Impact factor: 4.924

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.